Neutrophil cytosolic factor 1B (NCF1B)

Neutrophil cytosolic factor 1B (NCF1B) is a pseudogene related to NCF1 (neutrophil cytosolic factor 1).[1] While the functional NCF1 gene encodes p47-phox—a protein central to the NADPH oxidase complex in phagocytes and essential for reactive oxygen species (ROS) production—the NCF1B pseudogene does not produce a functional protein. It is predicted to share sequence similarity with the functional NCF1 gene but lacks evidence for being an active therapeutic target or participating in known biological pathways relevant to disease or drug action. NCF1B is therefore not considered a bona fide therapeutic target and does not have established involvement in pharmacology, pathology, or biomarker development.[1] Key points: - NCF1B is formally classified as a pseudogene and not as a protein-coding gene or therapeutic target[1]. - No known drugs, disease roles, or biomarker utility are associated with NCF1B, and it does not have a molecular or clinical function[1]. If you intended to ask about the functional gene neutrophil cytosolic factor 1 (NCF1, p47-phox), that target is involved in critical immune responses and is associated with conditions such as chronic granulomatous disease and hypertension, but NCF1B itself is not a valid drug target or receptor[1][2][5].

Other names

NCF-1BSH3PXD1Bputative SH3 and PX domain-containing protein 1Bputative neutrophil cytosol factor 1B